XML 42 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Of Financial Instruments (Tables)
 12 Months Ended
Jun. 30, 2019
Fair Value Of Financial Instruments [Abstract]  
Schedule Of Key Valuation Inputs Used To Measure Fair Value Of Investment In Cell C

 

Weighted Average Cost of Capital: Between 15% and 20% over the period of the forecast  
Long term growth rate: 4.5 %
Marketability discount: 10.0 %
Minority discount: 15.0 %
Net adjusted external debt(1) : ZAR 13.9 billion ($648.9 million), includes R6.4 billion of leases liabilities  
Deferred tax (incl. assessed tax losses(1) ): ZAR 2.9 billion ($20.6 million)  

 

(1) translated from ZAR to U.S. dollars at exchange rates applicable as of June 30, 2019.

 
Impact Of EBITDA Multiple
Sensitivity for fair value of Cell C investment   1% increase    1% decrease 
WACC rate $ - $ 9,632
EBITDA margin $ 9,875 $ -
Fair Value Of Assets And Liabilities Measured On Recurring Basis

     The following table presents the Company's assets measured at fair value on a recurring basis as of June 30, 2019, according to the fair value hierarchy:

    Quoted price in   Significant      
    active markets   other Significant    
    for identical   observable unobservable    
    assets   inputs inputs    
    (Level 1)   (Level 2) (Level 3)   Total
Assets              
Investment in Cell C $ - $ - $- $ -
Related to insurance business:              
Cash and cash equivalents (included in other              
long-term assets)   619   - -   619
Fixed maturity investments (included in              
cash and cash equivalents)   5,201   - -   5,201
Other   -   413 -   413
Total assets at fair value $ 5,820 $ 413 $- $ 6,233

 

     The following table presents the Company's assets and liabilities measured at fair value on a recurring basis as of June 30, 2018, according to the fair value hierarchy:

    Quoted price in   Significant        
    active markets   other   Significant    
    for identical   observable   unobservable    
    assets   inputs   inputs    
    (Level 1)   (Level 2)   (Level 3)   Total
Assets                
Investment in Cell C $ - $ - $ 172,948 $ 172,948
Related to insurance business:                
Cash and cash equivalents (included in other                
long-term assets)   610   -   -   610
Fixed maturity investments (included in                
cash and cash equivalents)   8,304   -   -   8,304
Other   -   18   -   18
Total assets at fair value $ 8,914 $ 18 $ 172,948 $ 181,880
Liabilities                
DNI contingent consideration (Note 3) $ - $ - $ 27,222 $ 27,222
Total liabilities at fair value $ - $ - $ 27,222 $ 27,222
Carrying Value Of Assets And Liabilities Measured On Recurring Basis
    Carrying value  
Assets      
Balance as at June 30, 2018 $ 172,948  
Loss on fair value re-measurements   (167,459 )
Foreign currency adjustment(1)   (5,489 )
Balance as of June 30, 2019 $ -  
Liabilities      
Balance as at June 30, 2018 $ 27,222  
Accretion of interest   1,848  
Settlement of contingent consideration (Note 3 and Note 20)   (27,626 )
Foreign currency adjustment(1)   (1,444 )
Balance as of June 30, 2019 $ -  

 

     (1) The foreign currency adjustment represents the effects of the fluctuations of the South African rand and the U.S. dollar on the carrying value.

 

    Carrying value  
Assets      
Acquisition of investment in Cell C $ 151,003  
Change in fair value of Cell C   32,473  
Foreign currency adjustment   (10,528 )
Balance as of June 30, 2018 $ 172,948